SEC Info - Kraig Biocraft Laboratories, Inc - ‘10-K’ for 12/31/14

SEC Info℠

Home

My Interests

Help

Please Sign In

Kraig Biocraft Laboratories, Inc – ‘10-K’ for 12/31/14 – ‘EX-32.1’

On: Tuesday, 3/31/15, at 3:01pm ET · For: 12/31/14 · Accession #: 1354488-15-1479 · File #: 333-146316

Previous ‘10-K’: ‘10-K’ on 4/15/14 for 12/31/13 · Next: ‘10-K’ on 3/30/16 for 12/31/15 · Latest: ‘10-K’ on 4/1/24 for 12/31/23 · 40 References:

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/31/15  Kraig Biocraft Laboratories, Inc  10-K       12/31/14   50:4.1M                                   Issuer Direct/FA

Annual Report — Form 10-K — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    760K 
 2: EX-4.1      Warrant                                             HTML     41K 
 5: EX-10.15    Intellectual Property/Collaborative Research        HTML     41K 
                Agreement                                                        
 3: EX-31.1     Certification -- §302 - SOA'02                      HTML     26K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     18K 
32: R1          Document and Entity Information                     HTML     45K 
24: R2          Balance Sheets                                      HTML     85K 
30: R3          Balance Sheets (Parenthetical)                      HTML     43K 
34: R4          Statements of Operations                            HTML     75K 
46: R5          Statements of Cash Flows                            HTML    109K 
25: R6          Statement of Changes in Stockholders Deficit        HTML    121K 
29: R7          Statement of Changes in Stockholders Deficit        HTML     47K 
                (Parenthetical)                                                  
22: R8          1. Summary of Significant Accounting Policies and   HTML     67K 
                Organization                                                     
16: R9          2. Going Concern                                    HTML     21K 
47: R10         3. Equipment                                        HTML     28K 
36: R11         4. Loan Payable                                     HTML     20K 
35: R12         5. Loan Payable-Related Party                       HTML     18K 
40: R13         6. Stockholders' Deficit                            HTML     80K 
41: R14         7. Commitments and Contingencies                    HTML     57K 
39: R15         8. Related Party Transactions                       HTML     31K 
42: R16         9. Subsequent Events                                HTML     21K 
31: R17         1. Summary of Significant Accounting Policies and   HTML    106K 
                Organization (Policies)                                          
33: R18         1. Summary of Significant Accounting Policies and   HTML     41K 
                Organization (Tables)                                            
38: R19         3. Equipment (Tables)                               HTML     23K 
50: R20         6. Stockholders' Deficit (Tables)                   HTML     64K 
44: R21         1. Summary of Significant Accounting Policies and   HTML     25K 
                Organization (Details)                                           
27: R22         1. Summary of Significant Accounting Policies and   HTML     31K 
                Organization (Details 1)                                         
37: R23         1. Summary of Significant Accounting Policies and   HTML     30K 
                Organization (Details 2)                                         
28: R24         1. Summary of Significant Accounting Policies and   HTML     25K 
                Organization (Details 3)                                         
15: R25         1. Summary of Significant Accounting Policies and   HTML     22K 
                Organization (Details Narrative)                                 
45: R26         2. Going Concern (Details Narrative)                HTML     26K 
48: R27         3. Equipment (Details)                              HTML     29K 
19: R28         3. Equipment (Details Narrative)                    HTML     19K 
18: R29         4. Loan Payable (Details Narrative)                 HTML     19K 
20: R30         6. Stockholders' Deficit (Details)                  HTML     73K 
21: R31         6. Stockholders' Deficit (Details 1)                HTML     45K 
23: R32         6. Stockholders' Deficit (Details 2)                HTML     31K 
13: R33         6. Stockholders' Deficit (Details 3)                HTML     21K 
43: R34         7. Commitments and Contingencies (Details           HTML     32K 
                Narrative)                                                       
26: R35         8. Related Party Transactions (Details Narrative)   HTML     49K 
49: XML         IDEA XML File -- Filing Summary                      XML     67K 
12: EXCEL       IDEA Workbook of Financial Reports                  XLSX    105K 
17: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS    382K 
 6: EX-101.INS  XBRL Instance -- kblb-20141231                       XML    654K 
 8: EX-101.CAL  XBRL Calculations -- kblb-20141231_cal               XML    104K 
 9: EX-101.DEF  XBRL Definitions -- kblb-20141231_def                XML    174K 
10: EX-101.LAB  XBRL Labels -- kblb-20141231_lab                     XML    612K 
11: EX-101.PRE  XBRL Presentations -- kblb-20141231_pre              XML    383K 
 7: EX-101.SCH  XBRL Schema -- kblb-20141231                         XSD    114K 
14: ZIP         XBRL Zipped Folder -- 0001354488-15-001479-xbrl      Zip     78K

‘EX-32.1’ — Certification — §906 – SOA’02

This Exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

C: C: C:

EXHIBIT 32.1

CERTIFICATION OF

CHIEF EXECUTIVE OFFICER

AND CHIEF FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350

In connection with the accompanying Annual Report on Form 10-K of Kraig Biocraft Laboratories, Inc. for the year ended December 31, 2014 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Kim Thompson, President, Chief Executive Officer and Chief Financial Officer of Kraig Biocraft Laboratories, Inc. hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:

1.	The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and

2.	The information contained in the Report fairly represents in all material respects, the financial condition and results of operations of Kraig Biocraft Laboratories, Inc.

Date: March 31, 2015



/s/ Kim Thompson
Kim Thompson President, Chief Executive Officer and Chief Financial Officer (principal executive officer, principal financial officer and principal accounting officer)

A signed original of this written statement required by Section 906 has been provided to Kraig Biocraft Laboratories, Inc. and will be retained by Kraig Biocraft Laboratories, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

Dates Referenced Herein and Documents Incorporated by Reference

This ‘10-K’ Filing	Date	Other Filings

Filed on:	3/31/15	10-Q
For Period end:	12/31/14
		List all Filings

40 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/14/24  Kraig Biocraft Laboratories, Inc. 10-Q        3/31/24   60:5.8M                                   M2 Compliance LLC/FA
 4/01/24  Kraig Biocraft Laboratories, Inc. 10-K       12/31/23   75:8.1M                                   M2 Compliance LLC/FA
11/22/23  Kraig Biocraft Laboratories, Inc. S-1/A                 67:13M                                    M2 Compliance LLC/FA
 9/01/23  Kraig Biocraft Laboratories, Inc. POS AM                67:13M                                    M2 Compliance LLC/FA
 9/01/23  Kraig Biocraft Laboratories, Inc. S-1/A                 67:13M                                    M2 Compliance LLC/FA
 8/14/23  Kraig Biocraft Laboratories, Inc. 10-Q        6/30/23   66:7.4M                                   M2 Compliance LLC/FA
 6/06/23  Kraig Biocraft Laboratories, Inc. S-1/A                 66:13M                                    M2 Compliance LLC/FA
 5/18/23  Kraig Biocraft Laboratories, Inc. 424B3                  1:739K                                   M2 Compliance LLC/FA
 5/12/23  Kraig Biocraft Laboratories, Inc. 10-Q        3/31/23   65:7.3M                                   M2 Compliance LLC/FA
 5/09/23  Kraig Biocraft Laboratories, Inc. S-1/A                  1:2.2M                                   M2 Compliance LLC/FA
 4/27/23  Kraig Biocraft Laboratories, Inc. S-1/A                  1:2.2M                                   M2 Compliance LLC/FA
 4/14/23  Kraig Biocraft Laboratories, Inc. S-1/A                 65:9.9M                                   M2 Compliance LLC/FA
 4/14/23  Kraig Biocraft Laboratories, Inc. POS AM                65:9.1M                                   M2 Compliance LLC/FA
 3/29/23  Kraig Biocraft Laboratories, Inc. 10-K       12/31/22   70:8.7M                                   M2 Compliance LLC/FA
12/01/22  Kraig Biocraft Laboratories, Inc. S-1/A                 65:14M                                    M2 Compliance LLC/FA
11/17/22  Kraig Biocraft Laboratories, Inc. 424B3                  1:1.1M                                   M2 Compliance LLC/FA
11/14/22  Kraig Biocraft Laboratories, Inc. 10-Q        9/30/22   64:7.2M                                   M2 Compliance LLC/FA
 8/12/22  Kraig Biocraft Laboratories, Inc. 424B3                  1:858K                                   M2 Compliance LLC/FA
 8/01/22  Kraig Biocraft Laboratories, Inc. 10-Q        6/30/22   63:6.8M                                   M2 Compliance LLC/FA
 5/25/22  Kraig Biocraft Laboratories, Inc. S-1/A                 64:12M                                    M2 Compliance LLC/FA
 5/10/22  Kraig Biocraft Laboratories, Inc. 424B3                  1:736K                                   M2 Compliance LLC/FA
 5/06/22  Kraig Biocraft Laboratories, Inc. 10-Q        3/31/22   64:6.3M                                   M2 Compliance LLC/FA
 4/14/22  Kraig Biocraft Laboratories, Inc. S-1/A                 65:10M                                    M2 Compliance LLC/FA
 3/23/22  Kraig Biocraft Laboratories, Inc. S-1/A                 65:9.7M                                   M2 Compliance LLC/FA
 3/16/22  Kraig Biocraft Laboratories, Inc. 10-K       12/31/21   69:9.6M                                   M2 Compliance LLC/FA
 2/10/22  Kraig Biocraft Laboratories, Inc. S-1                   67:13M                                    M2 Compliance LLC/FA
12/03/21  Kraig Biocraft Laboratories, Inc. S-1/A                 64:13M                                    M2 Compliance LLC/FA
11/05/21  Kraig Biocraft Laboratories, Inc. 10-Q        9/30/21   64:7.3M                                   M2 Compliance LLC/FA
 8/25/21  Kraig Biocraft Laboratories, Inc. S-1/A                 63:12M                                    M2 Compliance LLC/FA
 8/12/21  Kraig Biocraft Laboratories, Inc. 10-Q        6/30/21   63:6.5M                                   M2 Compliance LLC/FA
 5/26/21  Kraig Biocraft Laboratories, Inc. S-1/A                 86:9.3M                                   M2 Compliance LLC/FA
 5/10/21  Kraig Biocraft Laboratories, Inc. 10-Q        3/31/21   62:4.3M                                   M2 Compliance LLC/FA
 4/15/21  Kraig Biocraft Laboratories, Inc. S-1/A                  1:74K                                    M2 Compliance LLC/FA
 4/14/21  Kraig Biocraft Laboratories, Inc. S-1/A                  2:161K                                   M2 Compliance LLC/FA
 4/05/21  Kraig Biocraft Laboratories, Inc. S-1                   63:6M                                     M2 Compliance LLC/FA
 3/12/21  Kraig Biocraft Laboratories, Inc. 10-K       12/31/20   67:5.7M                                   M2 Compliance LLC/FA
 2/18/21  Kraig Biocraft Laboratories, Inc. S-1/A                 78:9.1M                                   M2 Compliance LLC/FA
 2/08/21  Kraig Biocraft Laboratories, Inc. S-1/A                 78:9.1M                                   M2 Compliance LLC/FA
11/10/20  Kraig Biocraft Laboratories, Inc. 10-Q        9/30/20   57:4.8M                                   M2 Compliance LLC/FA
 8/24/20  Kraig Biocraft Laboratories, Inc. S-1/A                 68:7.8M                                   M2 Compliance LLC/FA

↑Top

Filing Submission 0001354488-15-001479 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)